Pages that link to "Q73679002"
Jump to navigation
Jump to search
The following pages link to Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients (Q73679002):
Displaying 34 items.
- B-Raf specific antibody responses in melanoma patients (Q24794587) (← links)
- Survivin: a unique target for tumor therapy (Q26747332) (← links)
- Targeting survivin in cancer (Q27012954) (← links)
- De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma (Q31938591) (← links)
- Improving the prediction accuracy in classification using the combined data sets by ranks of gene expressions (Q33343730) (← links)
- Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model. (Q33723063) (← links)
- Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine (Q33887196) (← links)
- Clinical validation of an autoantibody test for lung cancer (Q34537374) (← links)
- Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2. (Q36065831) (← links)
- Antitumor cytotoxic T-cell response induced by a survivin peptide mimic (Q36155913) (← links)
- Tumor-associated antigen arrays for the serological diagnosis of cancer (Q36491988) (← links)
- Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity (Q36605447) (← links)
- Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma (Q36623798) (← links)
- Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma (Q36731844) (← links)
- Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma. (Q37348446) (← links)
- T-cell responses to survivin in cancer patients undergoing radiation therapy (Q37357113) (← links)
- Immunohistochemical expression and serum level of survivin protein in colorectal cancer patients (Q37407080) (← links)
- Cellular immunotherapy for soft tissue sarcomas. (Q37991779) (← links)
- AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches (Q38033116) (← links)
- Preclinical development of HIvax: Human survivin highly immunogenic vaccines (Q38867680) (← links)
- Novel vaccines for glioblastoma: clinical update and perspective (Q39043417) (← links)
- Fucoidan derived from Undaria pinnatifida induces apoptosis in human hepatocellular carcinoma SMMC-7721 cells via the ROS-mediated mitochondrial pathway (Q39141573) (← links)
- An antisense plasmid targeting survivin expression induces apoptosis and sensitizes hepatocarcinoma cells to chemotherapy (Q40579654) (← links)
- Survivin in brain tumors: an attractive target for immunotherapy (Q40638343) (← links)
- Diagnostic relevance of autoantibody detection against inhibitors of apoptosis proteins in colon cancer and colon adenoma (Q41766299) (← links)
- Bioelectric applications for treatment of melanoma (Q42872841) (← links)
- Survivin-Based Treatment Strategies for Squamous Cell Carcinoma. (Q51758973) (← links)
- Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas (Q51806652) (← links)
- Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT. (Q53378914) (← links)
- [Clinical significance and diagnostic value of Survivin autoantibody in non-small cell lung cancer patients]. (Q55428084) (← links)
- Aqueous Humor Markers in Retinoblastoma, a Review (Q64065507) (← links)
- Expression of survivin and its splice variants in gastric cancer (Q81166664) (← links)
- The Ectopic Expression of SurvivinT34A and FilC Can Enhance the Oncolytic Effects of Vaccinia Virus in Murine Gastric Cancer (Q89883757) (← links)
- Doxorubicin pretreatment enhances FAPα/survivin co-targeting DNA vaccine anti-tumor activity primarily through decreasing peripheral MDSCs in the 4T1 murine breast cancer model (Q94503530) (← links)